Quanta Therapeutics
Quanta Therapeutics discovers and develops small molecule drugs targeting RAS-driven cancers by modulating protein-protein interactions.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $50M
About
Quanta Therapeutics discovers and develops small molecule drugs targeting RAS-driven cancers by modulating protein-protein interactions.
OncologySmall Molecules
Funding History
1Total raised:$50M
Series D$50M